Markets
Stocks
Funds
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Recent Quotes
My Watchlist
Indicators
CRISPR THERAP N (NQ: CRSP)
58.35 USD  UNCHANGED
Streaming Delayed Price  /  Updated: 8:00 PM EDT, Jul 20, 2018  /  Add to My Watchlist      
View: Quote News Research
Price and Volume
Detailed Quote
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
Volume 534
Open 58.35
Bid (Size) 57.35 (1000)
Ask (Size) 58.50 (100)
Prev. Close 58.35
Today's Range 58.35 - 58.35
52wk Range 16.16 - 73.90
Shares Outstanding 46,842,969
Dividend Yield N/A
Performance
YTD
+131.82%
+131.82%
1 Month
-7.06%
-7.06%
3 Month
+17.64%
+17.64%
6 Month
+72.89%
+72.89%
1 Year
+241.43%
+241.43%
Top News
More News
Abingworth Raises $315m for ABV VII 12th Life Sciences Fund
from PR Newswire
Why This Partnership Could Help Stoke More Confidence For Celgene
Acceleron Pharma stock jumped Tuesday after it and Celgene reported a second win for their blood-disease drug called luspatercept. Acceleron shares were up more than 2% after earlier popping as much as... Read More
from Investor's Business Daily
More News
Read More
UPDATE 2-CRISPR gene editing can cause risky collateral DNA damage - study
category companyNews
from Reuters: Company News
UPDATE 1-CRISPR gene editing can cause risky collateral DNA damage - study
category companyNews
from Reuters: Company News
Yet Another CRISPR Worry: What Should Investors Do?
category NTLA , CRSP , EDIT , and 1 more.
from Motley Fool
CRISPR Therapeutics Stock History: The Rise of the World's Biggest Gene-Editing Biotech
category CRSP , Market News
from Motley Fool
Here's Why CRISPR Stocks Have Gained as Much as 169% in 2018 (So Far)
category EDIT , Market News , CRSP , and 1 more.
from Motley Fool
Here's Why CRISPR Therapeutics AG Fell 14.7% in June
category Market News , CRSP
from Motley Fool
Why bluebird bio's Shares Have Tumbled 11.9% in 2018 So Far
category VRTX , JNJ , CELG , and 5 more.
from Motley Fool
A Deep Dive Into The Latest CRISPR Controversy: Here’s What You Should Know
category NTLA , CRSP , EDIT , and 1 more.
from Motley Fool
Global Blood Therapeutics is gambling on its sickle cell drug — and investors aren’t happy
category PFE , GBT , Pharmaceuticals , and 10 more.
from MarketWatch
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Six Financial & Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.